Correction: Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer.

Stefanou, Dimitra T; Bamias, Aristotelis; Episkopou, Hara; Kyrtopoulos, Soterios A; Likka, Maria; Kalampokas, Theodore; Photiou, Stylianos; Gavalas, Nikos et al. · PLoS One · 2021

Where this comes from

Record sourced from PubMed, PMID 34352021.
Also identified by DOI 10.1371/journal.pone.0256051 and PMC identifier 8341518.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0117654.].

Read the full text

View on PubMed · Publisher (DOI)